biotechnetworks.bsky.social
@biotechnetworks.bsky.social
12 followers 10 following 1.1K posts
Posts Media Videos Starter Packs
TXBN Trending: Audio stress relief startup Audicin lands funding from Oura ring co-founders https://zpr.io/QY7xAgdatzSx
SDBN Trending: Cidara Therapeutics to Report Third Quarter 2025 Financial Results and Host Quarterly Conference Call on November 6, 2025 https://zpr.io/NMitCtmVCrMb
MWBN Trending: Sixteenth Street Community Health Centers buys property near flagship clinic https://zpr.io/8AiiGx7TRyXD
TXBN Trending: Memorial Hermann plans $282.5M Katy hospital expansion, latest in surge of suburban health care projects https://zpr.io/SMhiMd4xJwr6
BCBN Trending: STAT+: Pharmalittle: We’re reading about a Moderna setback, CVS playing hardball with Gilead, and more https://zpr.io/9NCah7HRJshP
SDBN Trending: Ionis ranked #2 Top Employer by Science magazine, recognizing industry-leading scientific innovation and company culture https://zpr.io/ZUWD7WCSNrr5
bionetworks Trending: BBOT Presents Preclinical Data Demonstrating Potential of BBO-11818 as a Potent panKRAS Inhibitor at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics https://zpr.io/CbUNv6ZhjjKK
DCBN Trending: Post-Hoc: Why we tracked pharma’s private jet flights to DC https://zpr.io/pCmjw32WWfDa
BCBN Trending: Startup’s tablets deliver cancer drugs more evenly over time https://zpr.io/xxatRXygXm2n
SDBN Trending: 10x, Roche, Prognosys Sue Illumina over Spatial and Single-Cell Patents https://zpr.io/3yC8j2qKACim
bionetworks Trending: Zenocutuzumab-zbco Granted FDA Breakthrough Therapy Designation for NRG1+ Cholangiocarcinoma; Data Highlighting Potential of Zenocutuzumab-zbco in NRG1+ Cholangiocarcinoma to be Presented at AACR-NCI-EORTC https://zpr.io/fEDPJD5XQxAn
SDBN Trending: Why It’s Not Just About Money: Who Goes to the Ballet, Opera and Symphony https://zpr.io/3QebKhKEJyf4
BCBN Trending: Gentuity Announces Activities and Presence to Showcase Advanced Intravascular Imaging Solutions at TCT 2025 https://zpr.io/cicCYJ7MyK6n
BCBN Trending: Rentschler Biopharma Inc. named Manufacturer of the Year for Central Massachusetts https://zpr.io/y8YXXGTrdwR9
SDBN Trending: $6.2M Grant Will Launch UC San Diego REACH Center for Translational Science on Whole Person Health https://zpr.io/rkij9kT5fyF7
SDBN Trending: GemPharmatech announces research collaboration with leading cancer center to advance antibody discovery https://zpr.io/29pDAJCngw6S
bionetworks Trending: BridGene Biosciences to Present Three Posters at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics https://zpr.io/QgP3PpUXDa9N
DCBN Trending: Consolidating Novavax transfers Maryland HQ lease to AstraZeneca in $60M deal https://zpr.io/wyXZKPjmF22B
SDBN Trending: Arcturus Therapeutics Provides Interim Phase 2 Data for Cystic Fibrosis (CF) Program https://zpr.io/3CeK2AJ5JQkQ
SDBN Trending: UC San Diego Pharmacy School Names Inaugural Chair of New Department https://zpr.io/ef6SDipXtqGN
SFBN Trending: PacBio to Report Third Quarter 2025 Financial Results on November 5, 2025 https://zpr.io/dkPf5Aqvmxu8
SFBN Trending: Cytek Biosciences to Report Third Quarter 2025 Financial Results on November 5, 2025 https://zpr.io/qc3GJ4RPGaLm
BCBN Trending: Vor Bio to Host Webcast on Late-Breaking China Phase 3 Telitacicept Data in Primary Sjögren’s Disease https://zpr.io/JYgWMjRGe27e
BCBN Trending: Takeda Enters Global Strategic Partnership with Innovent Biologics to Bolster Oncology Pipeline with Next-Generation Investigational Medicines for Treatment of Solid Tumors https://zpr.io/ZDHpjskps8jR
PNBN Trending: Malvern firm selling drug portfolio in potential $105M deal after FDA setback https://zpr.io/F8DuRSYLEgXV